Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Salinomycin increases chemosensitivity to the effects of doxorubicin in soft tissue sarcomas.

Liffers ST, Tilkorn DJ, Stricker I, Junge CG, Al-Benna S, Vogt M, Verdoodt B, Steinau HU, Tannapfel A, Tischoff I, Mirmohammadsadegh A.

BMC Cancer. 2013 Oct 21;13:490. doi: 10.1186/1471-2407-13-490.

2.

MicroRNA-205, a novel regulator of the anti-apoptotic protein Bcl2, is downregulated in prostate cancer.

Verdoodt B, Neid M, Vogt M, Kuhn V, Liffers ST, Palisaar RJ, Noldus J, Tannapfel A, Mirmohammadsadegh A.

Int J Oncol. 2013 Jul;43(1):307-14. doi: 10.3892/ijo.2013.1915. Epub 2013 Apr 23.

PMID:
23612742
3.

Growth rate of late passage sarcoma cells is independent of epigenetic events but dependent on the amount of chromosomal aberrations.

Becerikli M, Jacobsen F, Rittig A, Köhne W, Nambiar S, Mirmohammadsadegh A, Stricker I, Tannapfel A, Wieczorek S, Epplen JT, Tilkorn D, Steinstraesser L.

Exp Cell Res. 2013 Jul 15;319(12):1724-31. doi: 10.1016/j.yexcr.2013.03.023. Epub 2013 Mar 25.

PMID:
23535008
4.

Salinomycin induces autophagy in colon and breast cancer cells with concomitant generation of reactive oxygen species.

Verdoodt B, Vogt M, Schmitz I, Liffers ST, Tannapfel A, Mirmohammadsadegh A.

PLoS One. 2012;7(9):e44132. doi: 10.1371/journal.pone.0044132. Epub 2012 Sep 19.

5.

Site- and grade-specific diversity of LINE1 methylation pattern in gastroenteropancreatic neuroendocrine tumours.

Stricker I, Tzivras D, Nambiar S, Wulf J, Liffers ST, Vogt M, Verdoodt B, Tannapfel A, Mirmohammadsadegh A.

Anticancer Res. 2012 Sep;32(9):3699-706.

PMID:
22993308
6.

Inverse association of p16 INK4a and p14 ARF methylation of the CDKN2a locus in different Gleason scores of prostate cancer.

Verdoodt B, Sommerer F, Palisaar RJ, Noldus J, Vogt M, Nambiar S, Tannapfel A, Mirmohammadsadegh A, Neid M.

Prostate Cancer Prostatic Dis. 2011 Dec;14(4):295-301. doi: 10.1038/pcan.2011.45. Epub 2011 Sep 13.

PMID:
21912429
7.

MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B.

Liffers ST, Munding JB, Vogt M, Kuhlmann JD, Verdoodt B, Nambiar S, Maghnouj A, Mirmohammadsadegh A, Hahn SA, Tannapfel A.

Lab Invest. 2011 Oct;91(10):1472-9. doi: 10.1038/labinvest.2011.99. Epub 2011 Jun 27.

8.

A new two-phase dimeticone pediculicide shows high efficacy in a comparative bioassay.

Heukelbach J, Asenov A, Liesenfeld O, Mirmohammadsadegh A, Oliveira FA.

BMC Dermatol. 2009 Dec 14;9:12. doi: 10.1186/1471-5945-9-12.

9.

Role of erythropoietin receptor expression in malignant melanoma.

Mirmohammadsadegh A, Marini A, Gustrau A, Delia D, Nambiar S, Hassan M, Hengge UR.

J Invest Dermatol. 2010 Jan;130(1):201-10. doi: 10.1038/jid.2009.162.

10.

Transcriptional regulation of ASK/Dbf4 in cutaneous melanoma is dependent on E2F1.

Nambiar S, Mirmohammadsadegh A, Hassan M, Hegemann JH, Hengge UR.

Exp Dermatol. 2008 Dec;17(12):986-91. doi: 10.1111/j.1600-0625.2008.00730.x. Epub 2008 May 21.

PMID:
18503552
11.

Cutaneous melanoma: fishing with chips.

Nambiar S, Mirmohammadsadegh A, Hengge UR.

Curr Mol Med. 2008 May;8(3):235-43. Review.

PMID:
18473822
12.

The BH3-only member Noxa causes apoptosis in melanoma cells by multiple pathways.

Hassan M, Alaoui A, Feyen O, Mirmohammadsadegh A, Essmann F, Tannapfel A, Gulbins E, Schulze-Osthoff K, Hengge UR.

Oncogene. 2008 Jul 31;27(33):4557-68. doi: 10.1038/onc.2008.90. Epub 2008 Apr 14. Erratum in: Oncogene. 2011 Apr 28;30(17):2086.

PMID:
18408751
13.

Identification and functional characterization of ASK/Dbf4, a novel cell survival gene in cutaneous melanoma with prognostic relevance.

Nambiar S, Mirmohammadsadegh A, Hassan M, Mota R, Marini A, Alaoui A, Tannapfel A, Hegemann JH, Hengge UR.

Carcinogenesis. 2007 Dec;28(12):2501-10. Epub 2007 Sep 3.

PMID:
17768177
14.

ERK1/2 is highly phosphorylated in melanoma metastases and protects melanoma cells from cisplatin-mediated apoptosis.

Mirmohammadsadegh A, Mota R, Gustrau A, Hassan M, Nambiar S, Marini A, Bojar H, Tannapfel A, Hengge UR.

J Invest Dermatol. 2007 Sep;127(9):2207-15. Epub 2007 May 17.

15.

Epigenetic silencing of the PTEN gene in melanoma.

Mirmohammadsadegh A, Marini A, Nambiar S, Hassan M, Tannapfel A, Ruzicka T, Hengge UR.

Cancer Res. 2006 Jul 1;66(13):6546-52.

16.

STAT5 phosphorylation in malignant melanoma is important for survival and is mediated through SRC and JAK1 kinases.

Mirmohammadsadegh A, Hassan M, Bardenheuer W, Marini A, Gustrau A, Nambiar S, Tannapfel A, Bojar H, Ruzicka T, Hengge UR.

J Invest Dermatol. 2006 Oct;126(10):2272-80. Epub 2006 Jun 1.

17.

Epigenetic inactivation of tumor suppressor genes in serum of patients with cutaneous melanoma.

Marini A, Mirmohammadsadegh A, Nambiar S, Gustrau A, Ruzicka T, Hengge UR.

J Invest Dermatol. 2006 Feb;126(2):422-31.

18.

Constitutive expression of epidermal growth factor receptors on normal human melanocytes.

Mirmohammadsadegh A, Hassan M, Gustrau A, Doroudi R, Schmittner N, Nambiar S, Tannapfel A, Ruzicka T, Hengge UR.

J Invest Dermatol. 2005 Aug;125(2):392-4. No abstract available.

19.

Identification of functional genes during Fas-mediated apoptosis using a randomly fragmented cDNA library.

Hassan M, Mirmohammadsadegh A, Selimovic D, Nambiar S, Tannapfel A, Hengge UR.

Cell Mol Life Sci. 2005 Sep;62(17):2015-26.

PMID:
16091844
20.

Topical application of plasmid DNA to mouse and human skin.

Meykadeh N, Mirmohammadsadegh A, Wang Z, Basner-Tschakarjan E, Hengge UR.

J Mol Med (Berl). 2005 Nov;83(11):897-903. Epub 2005 May 19.

PMID:
15902389
21.

[Gene therapy and the skin].

Hengge UR, Bardenheuer W, Doroudi R, Mirmohammadsadegh A.

Ann Dermatol Venereol. 2005 Feb;132(2):154-63. Review. French. No abstract available.

PMID:
15798569
22.

Signaling networks in cutaneous melanoma metastasis identified by complementary DNA microarrays.

Nambiar S, Mirmohammadsadegh A, Doroudi R, Gustrau A, Marini A, Roeder G, Ruzicka T, Hengge UR.

Arch Dermatol. 2005 Feb;141(2):165-73.

PMID:
15724012
23.

Allele loss and epigenetic inactivation of 3p21.3 in malignant liver tumors.

Tischoff I, Markwarth A, Witzigmann H, Uhlmann D, Hauss J, Mirmohammadsadegh A, Wittekind C, Hengge UR, Tannapfel A.

Int J Cancer. 2005 Jul 10;115(5):684-9.

24.

Rapid identification of dysregulated genes in cutaneous malignant melanoma metastases using cDNA technology.

Mirmohammadsadegh A, Baer A, Nambiar S, Bardenheuer W, Hengge UR.

Cells Tissues Organs. 2004;177(3):119-23.

PMID:
15388985
25.

Applications of array technology: melanoma research and diagnosis.

Nambiar S, Mirmohammadsadegh A, Bär A, Bardenheuer W, Roeder G, Hengge UR.

Expert Rev Mol Diagn. 2004 Jul;4(4):549-57. Review.

PMID:
15225102
26.

Uptake and trafficking of DNA in keratinocytes: evidence for DNA-binding proteins.

Basner-Tschakarjan E, Mirmohammadsadegh A, Baer A, Hengge UR.

Gene Ther. 2004 May;11(9):765-74.

PMID:
14724668
27.

Molecular cloning and characterization of alternatively spliced mRNA isoforms from psoriatic skin encoding a novel member of the S100 family.

Wolf R, Mirmohammadsadegh A, Walz M, Lysa B, Tartler U, Remus R, Hengge U, Michel G, Ruzicka T.

FASEB J. 2003 Oct;17(13):1969-71. Epub 2003 Aug 15.

PMID:
12923069
28.
29.

HAX-1, identified by differential display reverse transcription polymerase chain reaction, is overexpressed in lesional psoriasis.

Mirmohammadsadegh A, Tartler U, Michel G, Baer A, Walz M, Wolf R, Ruzicka T, Hengge UR.

J Invest Dermatol. 2003 Jun;120(6):1045-51.

30.

Reaction of keratinocytes to exogenous DNA.

Mirmohammadsadegh A, Maschke J, Basner-Tschakarjan E, Bär A, Hengge Ul.

Cells Tissues Organs. 2002;172(2):86-95.

PMID:
12426485
31.

Opioid receptors on white blood cells: effect of HIV infection and methadone treatment.

Beck M, Mirmohammadsadegh A, Franz B, Blanke J, Hengge UR.

Pain. 2002 Jul;98(1-2):187-94.

PMID:
12098631
32.

Induction of acute phase response genes in keratinocytes following exposure to oligodeoxynucleotides.

Mirmohammadsadegh A, Maschke J, Basner-Tschakarjan E, Bär A, Hengge UR.

J Mol Med (Berl). 2002 Jun;80(6):377-83. Epub 2002 Mar 23.

PMID:
12072913
33.

Lymphocytes proliferate in blood and lymph nodes following interleukin-2 therapy in addition to highly active antiretroviral therapy.

Hengge UR, Borchard C, Esser S, Schröder M, Mirmohammadsadegh A, Goos M.

AIDS. 2002 Jan 25;16(2):151-60.

PMID:
11807298
34.

Safety and pharmacokinetics of naked plasmid DNA in the skin: studies on dissemination and ectopic expression.

Hengge UR, Dexling B, Mirmohammadsadegh A.

J Invest Dermatol. 2001 Jun;116(6):979-82.

35.

Adeno-associated virus expresses transgenes in hair follicles and epidermis.

Hengge UR, Mirmohammadsadegh A.

Mol Ther. 2000 Sep;2(3):188-94.

36.

Calgranulin C is overexpressed in lesional psoriasis.

Mirmohammadsadegh A, Tschakarjan E, Ljoljic A, Bohner K, Michel G, Ruzicka T, Goos M, Hengge UR.

J Invest Dermatol. 2000 Jun;114(6):1207-8. No abstract available.

37.

Differential IL-10 receptor gene expression in acute versus chronic atopic eczema. Modulation by immunosuppressive drugs and cytokines in normal cultured keratinocytes.

Müschen A, Mirmohammadsadegh A, Jarzebska-Deussen B, Abts HF, Ruzicka T, Michel G.

Inflamm Res. 1999 Oct;48(10):539-43.

PMID:
10563471
38.

Cloning and characterization of hurpin (protease inhibitor 13): A new skin-specific, UV-repressible serine proteinase inhibitor of the ovalbumin serpin family.

Abts HF, Welss T, Mirmohammadsadegh A, Köhrer K, Michel G, Ruzicka T.

J Mol Biol. 1999 Oct 15;293(1):29-39.

PMID:
10512713
40.
41.

1,25-(OH)2-vitamin D3 and calcipotriol induce IL-10 receptor gene expression in human epidermal cells.

Michel G, Gailis A, Jarzebska-Deussen B, Müschen A, Mirmohammadsadegh A, Ruzicka T.

Inflamm Res. 1997 Jan;46(1):32-4.

PMID:
9117516

Supplemental Content

Loading ...
Support Center